| 000 | 01624nam a2200373 a 4500 | ||
|---|---|---|---|
| 001 | ebr10674883 | ||
| 003 | CaPaEBR | ||
| 006 | m u | ||
| 007 | cr cn||||||||| | ||
| 008 | 100122s2010 nyuab sb 001 0 eng d | ||
| 010 | _z 2010002978 | ||
| 020 | _z9781616682330 (softcover) | ||
| 020 | _z1616682337 (softcover) | ||
| 020 | _z9781616684785 (e-book) | ||
| 040 |
_aCaPaEBR _cCaPaEBR |
||
| 035 | _a(OCoLC)682621157 | ||
| 050 | 1 | 4 |
_aRM409 _b.V56 2010eb |
| 082 | 0 | 4 |
_a615.5/8 _222 |
| 100 | 1 | _aVin�sov�a, Jarmila. | |
| 245 | 1 | 0 |
_aDevelopment of new MDR-tuberculosis drugs _h[electronic resource] / _cJarmila Vin�sov�a and Martin Kr�atk�y. |
| 260 |
_aNew York : _bNova Science Publishers/Nova Biomedical, _cc2010. |
||
| 300 |
_axii, 98 p. : _bill., map. |
||
| 490 | 1 | _aPharmacology-research, safety testing and regulation | |
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aResistance to commonly used drugs, mechanism of the action -- Research of novel MDR potential drugs. | |
| 533 |
_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2013. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries. |
||
| 650 | 0 | _aAntitubercular agents. | |
| 650 | 0 |
_aMultidrug-resistant tuberculosis _xChemotherapy. |
|
| 655 | 7 |
_aElectronic books. _2local |
|
| 700 | 1 |
_aKr�atk�y, Martin, _d1960- |
|
| 710 | 2 | _aebrary, Inc. | |
| 830 | 0 | _aPharmacology-research, safety testing, and regulation series. | |
| 856 | 4 | 0 |
_uhttp://site.ebrary.com/lib/rucke/Doc?id=10674883 _zAn electronic book accessible through the World Wide Web; click to view |
| 999 |
_c57295 _d57295 |
||